How ketamine and SSRIs/SNRIs compare for depression — speed, evidence, cost, side effects, and which to pick when standard pills fail.
Choosing between ketamine vs antidepressants for depression is really a question about speed, severity, and what you have already tried. Antidepressants like SSRIs and SNRIs are the standard first step — cheap, daily pills that take weeks to work. Ketamine is faster and far newer, and it is mainly used when standard pills have failed. This guide compares both side by side so you can talk to your doctor with clear questions.
Here is the short version. Use it to spot which option fits your situation, then read the sections below for detail.
| Factor | Ketamine | Antidepressants (SSRIs/SNRIs) |
|---|---|---|
| How it works | Blocks the NMDA glutamate receptor. Thought to spark fast new brain connections (synaptic plasticity). | Raise serotonin (SSRIs) or serotonin and norepinephrine (SNRIs) in the brain over time. |
| Speed of effect | Fast — relief often within hours to a few days.3 | Slow — usually 4–6 weeks for the full effect. |
| What it treats | Treatment-resistant depression; major depression with acute suicidal thoughts (Spravato). Off-label for anxiety, PTSD, pain. | First-line for major depression, anxiety disorders, OCD, panic, and more. |
| Evidence | Strong for rapid, short-term relief. Needs repeat dosing to hold. Long-term data still growing. | Decades of large trials. About 1 in 3 reach remission on the first one (STAR*D).1 |
| How you take it | Spravato nasal spray in a clinic; IV/IM infusions; off-label at-home oral lozenges via telehealth. | A pill you swallow once a day at home. |
| Cost & insurance | Expensive. Spravato is often covered for TRD. IV ($400–$800/session) and at-home oral usually are not. | Cheap. Most are generic and covered by insurance, often a few dollars a month. |
| Side effects | Short dissociation, raised blood pressure, nausea, dizziness. Bladder damage with chronic heavy use. | Nausea, sexual side effects, weight changes, sleep changes. Withdrawal if stopped fast. |
| Who it’s for | People who have tried two or more antidepressants without success, or who need fast relief. | Almost anyone starting depression treatment for the first time. |
The two treatments act on different brain systems. That is why their speed and use cases differ so much.
SSRIs and SNRIs change how your brain uses serotonin. SSRIs raise serotonin levels. SNRIs raise both serotonin and norepinephrine.
These shifts build up slowly. Most people need 4 to 6 weeks before they feel the full effect. That wait is the main drawback of first-line pills.
Ketamine works on a different target called the NMDA glutamate receptor. By blocking it, ketamine appears to trigger a quick burst of new brain connections.
This is why relief can come in hours, not weeks. Learn more in our full ketamine therapy guide, which covers IV infusions, Spravato, and at-home options.
Both treatments have real research behind them. But the evidence answers different questions.
Antidepressants have decades of large trials. The landmark STAR*D study followed nearly 3,000 patients. About 28–33% reached full remission on the first antidepressant they tried.1
That is not perfect, but it is solid. Many who do not respond to the first drug get better after switching or adding a second.
Ketamine’s strength is speed. Trials show a rapid antidepressant effect within hours of a single low dose.3 For people in crisis, that speed can be lifesaving.
The catch is durability. A single dose often fades within days to weeks. That is why clinics use a repeat schedule.
In January 2025, the FDA approved Spravato as the first standalone treatment for treatment-resistant depression. In its key trial, 22.5% of patients reached remission by week 4, versus 7.6% on placebo.2
Cost is often the deciding factor. Here the two options are very far apart.
Not sure which path fits your budget and history? Our depression treatment path tool compares Spravato, IV ketamine, and other options step by step.
Yes, and many people do. This is one of the most common questions, and the answer surprises people.
Most ketamine clinics keep you on your existing antidepressant. The two work on different systems, so they do not cancel each other out the way an SSRI can blunt psilocybin. Spravato was first approved to be used alongside a daily oral antidepressant.
Search intent here is simple: people want to know which one fits them. Here is a plain-English guide.
In the ketamine vs antidepressants choice, there is no single winner — the right pick depends on your stage of treatment. For most people, antidepressants are the smart first move. They are safe, cheap, well-studied, and easy to take at home.
Ketamine earns its place when standard pills fail or when speed matters. It is faster and works in harder cases, but it costs more and needs medical supervision. The good news is you rarely have to choose one forever. Many people stay on an antidepressant while adding ketamine, guided by a doctor.
Your next step is a conversation with a qualified prescriber. Map your options with our depression treatment path tool, then use find a ketamine provider to compare real clinics near you.
Neither is simply better — they fit different situations. Antidepressants are the first-line choice because they are safe, cheap, and easy to take at home, but they take 4-6 weeks to work. Ketamine works far faster (hours to days) and helps in harder cases, but it costs more and needs medical supervision. For most people, doctors start with antidepressants and consider ketamine if those fail.
Not on your own. Most ketamine clinics keep you on your existing SSRI or SNRI, and Spravato was first approved to be used alongside a daily antidepressant. In January 2025 the FDA also approved Spravato as a standalone treatment for treatment-resistant depression, but that decision belongs to your prescriber. Never stop an antidepressant suddenly — it can cause withdrawal and relapse. Any change must be tapered with your doctor.
Treatment-resistant depression means at least two antidepressants have not worked. For these patients, ketamine — usually as FDA-approved Spravato (esketamine) — is a leading option because it acts on a different brain system (glutamate) and works quickly. In its key trial, 22.5% of patients reached remission by week 4 versus 7.6% on placebo. Doctors often continue a daily antidepressant during ketamine treatment rather than switching.
Generally yes, and it is common. Ketamine works on the NMDA glutamate receptor while SSRIs and SNRIs work on serotonin, so they do not cancel each other out the way an SSRI can blunt psilocybin. Most clinics keep patients on their antidepressant. Still, your prescriber must review every medication you take, including any that raise blood pressure, before you start ketamine.
Get psychedelic research & policy updates
New trials, FDA decisions, and legal changes for psychedelic — delivered when they happen.
Suggest a tool, topic, or improvement that would make this site more useful.